Össur
Össur is an Icelandic medical-device company specializing in prosthetics, orthopaedic bracing and supports, compression therapy, and bionic limb technologies.
Last updated September 23, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Össur is an Icelandic medical-technology company that develops, manufactures, and sells non-invasive orthopaedic equipment. Its principal activities are organized around three related markets: bracing and support, compression therapy, and prosthetics, including electronically controlled and powered bionic systems. The company serves people with limb loss, limb difference, musculoskeletal injuries, joint instability, osteoarthritis, circulatory needs, and other conditions requiring external orthopaedic support. The company was founded in Iceland in 1971 by Össur Kristinsson, a prosthetist. In its early years it was a family-owned business focused on the domestic Icelandic market. Össur began exporting in 1986, which marked the beginning of its transition from a local prosthetic provider into an international medical-device company. The family ownership ended when the company became publicly traded in 1999 and was listed on the Iceland Stock Exchange. It subsequently expanded its geographic reach and product portfolio through a sustained program of acquisitions. Össur has been listed on Nasdaq Copenhagen since 2009. Prosthetics remain central to the brand. Its portfolio includes prosthetic feet, knees, liners, sockets, locks, sleeves, and related interfaces. The Flex-Foot carbon-fiber family helped establish Össur as a major developer of energy-storing prosthetic feet. Its Cheetah running foot became particularly visible through use by para-athletes, while other product families address everyday mobility and clinical rehabilitation. The company also produces the Total Knee and Mauch Knee, as well as Iceross silicone liners designed to improve the interface between a residual limb and a prosthetic socket. Össur's bionic portfolio extends conventional passive prosthetics with microprocessor control, artificial intelligence, sensors, and powered movement. Examples include the Rheo Knee, the motor-powered Power Knee, and the Proprio Foot. These products are intended to help users manage stance, swing, balance, and propulsion in ways that more closely resemble biological movement. Össur has also worked with the Alfred Mann Foundation on implantable myoelectric control technology for prosthetic limbs, seeking longer-term improvements in how users operate advanced devices. The bracing and support business includes products for the knee, ankle, arm, and torso. Unloader One is designed to mechanically reduce load on an affected side of the knee for people with osteoarthritis, while CTi is a ligament-support brace used in rehabilitation and injury prevention. The company also supplies cervical collars and other orthotic supports. Össur entered compression therapy through its acquisition of the French Gibaud business, adding bandages, tights, stockings, knee-high garments, and stump socks. Össur's international model combines company offices in the Americas, Europe, and Asia with distributors in additional markets. It has expanded through more than 20 acquisitions since 2000, including Flex-Foot, Touch Bionics, College Park Industries, Naked Prosthetics, and FIOR & GENTZ. The company maintains research and development activities in several countries and collaborates with universities and specialist research organizations. In 2006, the World Economic Forum recognized Össur as a technology pioneer. The company also maintains Team Össur, an international sponsorship program for para-athletes, linking its technology and brand identity with elite sport and disability visibility.
History
Össur was established in Iceland in 1971 by Össur Kristinsson, a prosthetist. The founding business was initially oriented toward the Icelandic market and operated as a family-owned company. Its early focus was prosthetic care and related products, but the company later broadened its activities into orthotic bracing, support products, and compression therapy. A major early turning point came in 1986, when Össur began exporting. International sales allowed the company to move beyond the limits of its home market and created the basis for subsequent expansion. In 1999, after the family ownership period, Össur became publicly traded and was listed on the Iceland Stock Exchange. From 2000 onward, the company pursued an acquisition-led strategy, buying businesses and technologies in prosthetics, orthotics, sports medicine, compression, and clinical distribution. Acquisitions included Skóstofan, Flex-Foot, PI Medical, Karlsson & Bergstrom, Century XXII Innovations, Linea Orthopedics, Generation II Group, Advanced Prosthetic Components, Royce Medical, Innovative Medical Products, GBM Medical, Innovation Sports, Gibaud, SOMAS, Orthopaedic Partner Africa, Evolution Industries, TeamOlmed, Touch Bionics, Medi Prosthetics, College Park Industries, Naked Prosthetics, and FIOR & GENTZ. The acquisition of Flex-Foot strengthened Össur's position in carbon-fiber prosthetic feet. Carbon-fiber energy-storage technology became an important part of the company's identity, with the Flex-Foot family serving both everyday users and athletic applications. The Cheetah derivative gained international recognition through para-athletic use. Össur also developed a wider prosthetic systems business covering liners, sockets, sleeves, locks, and knees. The Iceross silicone liner became a notable component of the socket interface, while the Total Knee and Mauch Knee addressed different clinical and mobility requirements. Össur expanded its technology ambitions through electronically controlled and powered prostheses. The Rheo Knee introduced microprocessor control for swing and stance management. The Power Knee added motor assistance intended to synchronize movement with the user's sound leg, and the Proprio Foot used sensors and intelligent control to adapt foot behavior. The company's bionics work also included collaboration with the Alfred Mann Foundation on implantable myoelectric sensors. This research sought to create more direct and intuitive control of prosthetic limbs, although the technology remained an area of development rather than a universal commercial replacement for conventional control methods. The company broadened its non-prosthetic business through bracing and support products. Unloader One was developed to reduce load on a painful side of the knee, particularly in osteoarthritis, and CTi became a ligament-support brace used in rehabilitation and prevention. Össur's purchase of Gibaud provided entry into compression therapy, including stockings, tights, bandages, knee highs, and stump socks. These activities gave the company a more diversified orthopaedic offering than a prosthetics-only manufacturer. Össur began trading on Nasdaq Copenhagen in 2009. It developed an international operating network with offices in the Americas, Europe, and Asia and distributors in other markets. In 2006, the World Economic Forum named the company a technology pioneer. By 2019, the company reported more than 3,500 employees across over 25 locations and marked two decades as a public company with a Nasdaq ceremony in New York. Its brand visibility has also been supported by Team Össur, which sponsors international para-athletes and connects product development with high-performance sport. The acquisitions of College Park Industries in 2019, Naked Prosthetics in 2023, and FIOR & GENTZ in 2024 continued the company's strategy of adding specialist prosthetic and orthotic capabilities.
- 2024
FIOR & GENTZ acquisition
[1]Össur expands its orthotic portfolio through the acquisition of FIOR & GENTZ.
- 2023
Naked Prosthetics acquisition
[1]The company adds specialist partial-hand and finger prosthetic capabilities through the acquisition of Naked Prosthetics.
- 2019
College Park Industries acquisition
[1]Össur acquires College Park Industries and marks 20 years as a publicly traded company.
- 2016
Touch Bionics acquisition
[1]Össur acquires Touch Bionics, strengthening its position in advanced upper-limb prosthetics and bionic technology.
- 2009
Nasdaq Copenhagen listing
[1]Össur becomes listed on Nasdaq Copenhagen.
- 2006
Recognized as a technology pioneer
[1]The World Economic Forum names Össur a technology pioneer.
- 2000
Acquisition program accelerates
[1]Össur acquires several businesses, including Flex-Foot, expanding its prosthetic-foot and international operating capabilities.
- 1999
The company becomes publicly traded
[1]Össur ends its family-owned period and is listed on the Iceland Stock Exchange.
- 1986
International exporting begins
[1]Össur begins exporting its products, initiating its transformation from a local Icelandic business into an international supplier.
- 1971
Össur is founded in Iceland
[1]Prosthetist Össur Kristinsson establishes the company, initially serving the domestic Icelandic market.
Products and positioning
A global specialist in orthopaedic and prosthetic technology, positioned around clinical performance, mobility, user independence, and increasingly intelligent or powered solutions for people with limb loss and musculoskeletal conditions.
Prosthetic foot
Flex-Foot
A carbon-fiber prosthetic-foot family designed to store and return energy during walking and running. Its construction uses the strength and flexibility of carbon fiber to support dynamic movement. The line includes products for general mobility as well as athletic applications and helped establish Össur as a major prosthetic-foot developer.
Running prosthesis
Flex-Foot Cheetah
A curved carbon-fiber running foot derived from the Flex-Foot platform. The Cheetah is designed for high-performance running and has been used by prominent para-athletes, making it one of Össur's most recognizable products beyond clinical settings.
Microprocessor prosthetic knee
Rheo Knee
A microprocessor-controlled knee system that manages swing and stance behavior using sensors and electronic control. The product is intended to provide a more adaptable gait across changing walking conditions than a purely mechanical knee.
Powered prosthetic knee
Power Knee
A motor-powered prosthetic knee designed to provide active extension assistance. Its control system seeks to coordinate the prosthesis with the user's sound leg, supporting movement that requires more than passive energy storage and return.
Intelligent powered prosthetic foot
Proprio Foot
An electronically controlled and motor-powered foot module. It uses intelligent control to adjust its behavior during movement and is part of Össur's effort to reproduce selected functions of an anatomical foot through sensors, software, and powered mechanisms.
Prosthetic liner
Iceross
A family of silicone prosthetic liners that forms an interface between a residual limb and the prosthetic socket. The liners are intended to improve comfort, suspension, and skin protection while helping users manage the daily connection between the body and prosthesis.
Knee brace
Unloader One
A knee brace designed to mechanically unload the affected side of the knee. It is used particularly in connection with osteoarthritis, where reducing pressure on a damaged joint compartment may help manage pain and support mobility.
Ligament knee brace
CTi
A structural knee brace intended to support ligaments during rehabilitation and physical activity. The product was formerly sold under the CTi2 name and is also used for injury prevention and protection in sports and clinical contexts.
Hydraulic prosthetic knee
Mauch Knee
A prosthetic knee using hydraulic control to regulate movement and support a smoother, more natural gait. It represents a mechanically controlled approach within Össur's broader portfolio of prosthetic knee technologies.
Prosthetic knee
Total Knee
A prosthetic knee incorporating a locking moment when the knee reaches full extension. This feature is intended to help prevent uncontrolled collapse and provide stability during the gait cycle.
Marketing campaigns
- Team Össur
International
Össur sponsors a group of international para-athletes, including Sarah Reinertsen, Markus Rehm, Jody Cundy, and Rudy Garcia-Tolson. The program connects the brand with elite sport, demonstrates prosthetic technology in demanding environments, and promotes visibility for athletes with limb difference.
Outcome. The program serves as an ongoing athlete-sponsorship and brand-visibility platform.
Brand decisions
2024
Acquisition of FIOR & GENTZM&ABackground
FIOR & GENTZ was a specialist orthotic business whose capabilities complemented Össur's lower-limb mobility and orthopaedic portfolio.
Action taken
Össur acquired FIOR & GENTZ.
Aftermath
The transaction expanded Össur's orthotic offering and continued its specialist-acquisition strategy.
2023
Acquisition of Naked ProstheticsM&ABackground
Össur wanted to expand its prosthetics offering into more specialized solutions for partial-hand and finger amputations.
Action taken
Össur acquired Naked Prosthetics.
Aftermath
The acquisition broadened Össur's coverage of upper-limb and partial-hand prosthetic needs.
2019
Bionic prosthetics research agreement is extendedProduct launchBackground
Össur and the Alfred Mann Foundation had been investigating implantable myoelectric sensors for more direct prosthetic control.
Action taken
The organizations signed an agreement extending their collaboration on implantable control technology.
Aftermath
The agreement continued research into mind-directed or implant-assisted prosthetic control, with commercial development remaining a longer-term objective.
2009
Össur moves its public-market listing to Nasdaq CopenhagenStrategyBackground
The company had outgrown its original Icelandic public-market setting as its business became increasingly international.
Action taken
Össur became listed on the Nasdaq Copenhagen Stock Exchange.
Aftermath
The listing aligned the company with a larger Nordic capital market while it continued operating internationally.
2000
Acquisition-led international expansion beginsM&ABackground
Össur sought to broaden its product range and geographic reach beyond its original Icelandic base.
Action taken
The company began a sustained acquisition program, including the purchase of Flex-Foot and several other prosthetic and orthopaedic businesses.
Aftermath
The strategy expanded Össur's technology base, distribution footprint, and presence across prosthetics, bracing, sports medicine, and compression therapy.
1999
Össur transitions to public ownershipStrategyBackground
The company had been owned by the founder's family since its establishment.
Action taken
Össur became publicly traded and was listed on the Iceland Stock Exchange.
Aftermath
The change provided a public-company structure for international expansion and later acquisitions.
1986
Össur adopts an export-oriented growth strategyStrategyBackground
The company had initially concentrated on Iceland, a small domestic market, and needed international sales to support broader growth.
Action taken
Össur began exporting its products and subsequently developed an international network of offices and distributors.
Aftermath
Exporting established the foundation for the company's later international expansion and acquisition program.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/össur · Editorial policy · How profiles are compiled